Skip to content

Company information lookup

PRIMA BIOMED LTD (PRR)

biotechnology and medical research

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
PRR 0.039 0% 0.038 0.039 0.039 0.040 0.039 1,715,720

PRIMA BIOMED LTD details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code PRR
Securities
Official Listing Date 23 June, 1988
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address http://www.primabiomed.com.au
Registered Office Address Level 7, 151 Macquarie Street, SYDNEY, NSW, AUSTRALIA, 2000
Head Office Telephone +61 2 9276 1224
Head Office Fax (02) 9276 1284
Share Registry BOARDROOM PTY LIMITED
LEVEL 7, 207 KENT STREET, SYDNEY, NSW, AUSTRALIA, 2000
Share Registry Telephone (02) 9290 9600
Directors / Senior Management
Ms Lucy Turnbull A.O. (Chairman)
Mr Albert Wong (Deputy Chairman, Non Exec. Director)
Mr Marc Voigt (CEO, Executive Director, CFO)
Dr Russell John Howard (Non Exec. Director)
Mr Pete Meyers (Non Exec. Director)
Ms Deanne Miller (General Counsel)
Company Secretary Ms Deanne Miller
Principal Activities biotechnology and medical research

PRIMA BIOMED LTD announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
27/08/2014 asterix Appendix 4E & 2014 Full Year Statutory Accounts 81 PDF
19/08/2014   Prima to present at Society for Immunotherapy of Cancer 1 PDF
31/07/2014   Prima Newsletter 8 PDF
31/07/2014 asterix Appendix 4C - quarterly 5 PDF
22/07/2014   CEO Terms of Employment 2 PDF
16/07/2014 asterix Prima receives US patent grant for CVac 2 PDF
15/07/2014   Initial Director's Interest Notice 2 PDF
15/07/2014   Final Director's Interest Notice 2 PDF
09/07/2014 asterix Prima appoints new CEO 2 PDF
23/06/2014   Journal for Immunotherapy of Cancer Publication 1 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
12 Sep 2014 0.039 2.63% 0.039 0.038 336,611
11 Sep 2014 0.038 0% 0.038 0.037 818,778
10 Sep 2014 0.038 2.7% 0.038 0.037 394,197
09 Sep 2014 0.037 0% 0.038 0.037 520,229
08 Sep 2014 0.037 0% 0.038 0.037 514,000

* Volume of shares shown represents only those shares traded on ASX.

PRIMA BIOMED LTD price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security PRR. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security PRR

Warrants & Structured Products

No warrants & Structured Products are available over the security PRR

ASX CFDs

No Contracts For Differences are available over the security PRR